Parliamentary questions

221. Deputy Emer Currie asked the Minister for Health if she has met with or otherwise engaged with an organisation (details supplied); and if her Department has assessed the potential benefits of supporting home sharing as means of provide independent living and home support, particularly for older persons. [46253/26]

222. Deputy Pádraig O'Sullivan asked the Minister for Health for a full list of all drugs considered by the drugs group in 2025 and 2026, together with the recommendation in respect of each drug; and if she will make a statement on the matter. [46338/26]

223. Deputy Marie Sherlock asked the Minister for Health the way in which the €175 million levy to her Department will be applied; and what will be the change to the Departmental funding allocated to the HSE for 2026. [46355/26]

224. Deputy Marie Sherlock asked the Minister for Health the HSE's financial outturn relative to its budget for the period 1 January 2026 to 31 May 2026 and for the same period in 2025 and 2024. [46356/26]

225. Deputy Réada Cronin asked the Minister for Health the reason skyclarys is not included on the agenda for the upcoming HSE Drugs Group meeting; and if she will make a statement on the matter. [46373/26]

226. Deputy Réada Cronin asked the Minister for Health the number of patients currently on an outpatient waiting list at Naas General Hospital; and if she will make a statement on the matter. [46374/26]

227. Deputy Réada Cronin asked the Minister for Health the measures being taken to reduce waiting times at the accident and emergency department of Naas General Hospital; and if she will make a statement on the matter. [46375/26]

228. Deputy Réada Cronin asked the Minister for Health to provide a detailed plan on addressing hospital overcrowding in Naas General Hospital [46376/26]

229. Deputy Réada Cronin asked the Minister for Health the measures being taken to reduce waiting lists for outpatient services at Naas General Hospital; and if she will make a statement on the matter. [46377/26]

230. Deputy John Clendennen asked the Minister for Health the average wait time for the processing of Garda vetting applications for prospective HSE staff across all disciplines, including but not limited to nurses, speech and language therapists and doctors for the years 2024, 2025 and to date in 2026, the factors contributing to processing delays specifically affecting healthcare workers; and if…

231. Deputy John Clendennen asked the Minister for Health her assessment of the impact that delays in the return of Garda vetting for HSE staff are having on the provision of frontline healthcare services and the delivery of care to patients; whether specific services such as speech and language therapy or nursing have been disproportionately affected by these delays; and if she will make a statem…

232. Deputy John Clendennen asked the Minister for Health the number of prospective HSE staff, including nurses, doctors and allied health professionals, who were successful in their applications but whose start dates have been delayed due to waiting on the return of Garda vetting in 2024, 2025 and to date in 2026; the average length of such delays from the time a job offer is accepted to the comm…

233. Deputy John Clendennen asked the Minister for Health if her Department or the HSE currently operates any national key performance indicators governing recruitment clearance timelines, specifically regarding the time taken from submission of a Garda vetting application to its completion for HSE staff; and if she will make a statement on the matter. [46402/26]

234. Deputy John Clendennen asked the Minister for Health whether she has engaged with the Minister for Justice; Home Affairs and Migration regarding the implementation of a portable Garda vetting system specifically tailored for healthcare workers moving between roles or locations within the HSE or funded agencies to reduce administrative burdens and prevent delays in staff commencing work; and i…

235. Deputy Peadar Tóibín asked the Minister for Health regarding Delegation Reference No. 23/15 the date on which it was revoked (details supplied). [46404/26]

821. Deputy Conor Sheehan asked the Minister for Health the reason Skyclarys is not included on the agenda for the upcoming HSE drugs group meeting; if this drug will be put on the agenda for this meeting; and if she will make a statement on the matter. [44885/26]

822. Deputy Pearse Doherty asked the Minister for Health the reason a patient (details supplied) in County Donegal has been waiting for three weeks for transfer from Letterkenny University Hospital, for urgent life-saving surgery; and if she will make a statement on the matter. [44887/26]

823. Deputy Paul Nicholas Gogarty asked the Minister for Health the actions she is taking in liaison with the HSE to ensure a timely pricing and reimbursement scheme for givinostat (duvyzat), given that it is a year since conditional marketing authorisation was granted and it is a year since she met with families of children with DM and MDI and six months since she spoke at a national conference (…

824. Deputy Paul Nicholas Gogarty asked the Minister for Health the reasons provided by the HSE regarding the delay in processing the pricing and reimbursement application for givinostat, especially since 15 January 2026 when a full HTA dossier was submitted by a company (details supplied) to the NCPE; and if she will make a statement on the matter. [44892/26]

825. Deputy Paul Nicholas Gogarty asked the Minister for Health if she has been briefed by the HSE Drugs Group which was due to meet on 10 June 2026 to consider givinostat for reimbursement; if clear timelines for rollout have now been provided; if there will be proactive engagement with the HSE and clinical teams to ensure planning begins urgently, in order that implementation does not become a f…

826. Deputy Paul Nicholas Gogarty asked the Minister for Health the steps she has taken to ensure that eligibility criteria for givinostat are aligned with the NICE approach, ensuring access for boys who can walk or who can stand with or without support, in order that boys here are not disadvantaged compared to those in the Northern Ireland and receive equitable access to treatment; and if she wil…

827. Deputy Pearse Doherty asked the Minister for Health the reason an Adult Nursing and Midwifery Board of Ireland (NMBI) application for qualification recognition by a person (details supplied) in County Donegal who has completed a Masters in (Adult) Nursing at Queen's University Belfast was unsuccessful; and if she will make a statement on the matter. [44895/26]

828. Deputy Duncan Smith asked the Minister for Health the position regarding omnipods being covered by the HSE for individuals with type one diabetes; and if she will make a statement on the matter. [44898/26]

829. Deputy Michael Healy-Rae asked the Minister for Health if a company (details supplied) is allowed to change all policies so that it no longer covers 100% for orthopaedic procedures and that the company can leave patients to pay the 20% short fall; and if she will make a statement on the matter. [44902/26]

830. Deputy Eoghan Kenny asked the Minister for Health if her Department has further considered the inclusion of Skyclarys (omaveloxolone) as of June 2026, which is a treatment for Friedreich's ataxia in a reimbursement scheme given the cost of the drug and the fact that other European countries provide this scheme to patients; and if she will make a statement on the matter. [44904/26]